skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Nanoparticle conjugation enhances the immunomodulatory effects of intranasally delivered CpG in house dust mite-allergic mice

Journal Article · · Scientific Reports
DOI:https://doi.org/10.1038/srep14274· OSTI ID:1222943
 [1];  [1];  [1];  [1];  [2];  [1];  [1]
  1. Ecole polytechnique fédérale de Lausanne (Switzerland). Institute of Bioengineering
  2. Univ. de Lausanne (UNIL) (Switzerland)

An emerging strategy in preventing and treating airway allergy consists of modulating the immune response induced against allergens in the lungs. CpG oligodeoxynucleotides have been investigated in airway allergy studies, but even if promising, efficacy requires further substantiation. We investigated the effect of pulmonary delivery of nanoparticle (NP)-conjugated CpG on lung immunity and found that NP-CpG led to enhanced recruitment of activated dendritic cells and to Th1 immunity compared to free CpG. We then evaluated if pulmonary delivery of NP-CpG could prevent and treat house dust mite-induced allergy by modulating immunity directly in lungs. When CpG was administered as immunomodulatory therapy prior to allergen sensitization, we found that NP-CpG significantly reduced eosinophilia, IgE levels, mucus production and Th2 cytokines, while free CpG had only a moderate effect on these parameters. In a therapeutic setting where CpG was administered after allergen sensitization, we found that although both free CpG and NP-CpG reduced eosinophilia and IgE levels to the same extent, NP conjugation of CpG significantly enhanced reduction of Th2 cytokines in lungs of allergic mice. Taken altogether, these data highlight benefits of NP conjugation and the relevance of NP-CpG as allergen-free therapy to modulate lung immunity and treat airway allergy.

Research Organization:
Argonne National Laboratory (ANL), Argonne, IL (United States)
Sponsoring Organization:
European Research Council (ERC); Swiss National Science Foundation (SNSF); USDOE Office of Science (SC), Basic Energy Sciences (BES). Materials Sciences and Engineering Division
Grant/Contract Number:
AC02-06CH11357
OSTI ID:
1222943
Alternate ID(s):
OSTI ID: 1332964
Journal Information:
Scientific Reports, Vol. 5; ISSN 2045-2322
Publisher:
Nature Publishing GroupCopyright Statement
Country of Publication:
United States
Language:
English
Citation Metrics:
Cited by: 35 works
Citation information provided by
Web of Science

References (57)

Mucosal immunotherapy with CpG oligodeoxynucleotides reverses a murine model of chronic asthma induced by repeated antigen exposure journal November 2003
Immunological mechanisms of allergen-specific immunotherapy journal October 2006
The role of allergy in the development of asthma journal November 1999
Intranasal CpG DNA therapy during allergen exposure in allergic rhinitis journal February 2007
Nanoparticle conjugation of CpG enhances adjuvancy for cellular immunity and memory recall at low dose journal November 2013
PPS nanoparticles as versatile delivery system to induce systemic and broad mucosal immunity after intranasal administration journal January 2011
Bacterial-induced protection against allergic inflammation through a multicomponent immunoregulatory mechanism journal March 2011
CpG oligodeoxynucleotides do not require TH1 cytokines to prevent eosinophilic airway inflammation in a murine model of asthma☆☆☆★ journal December 1999
Synthesis of Pyridyl Disulfide-Functionalized Nanoparticles for Conjugating Thiol-Containing Small Molecules, Peptides, and Proteins journal April 2010
The cell biology of asthma journal June 2014
Nanoparticle conjugation and pulmonary delivery enhance the protective efficacy of Ag85B and CpG against tuberculosis journal September 2011
A Protective Allergy Vaccine Based on CpG- and Protamine-Containing PLGA Microparticles journal May 2007
Therapeutic potential of Toll-like receptor 9 activation journal June 2006
Nanoparticles target distinct dendritic cell populations according to their size journal May 2008
The dendritic cell mannose receptor mediates allergen internalization and maturation involving notch 1 signalling: MR mediates allergen internalization and maturation of DC journal September 2010
Expression of Toll-like Receptor 9 in nose, peripheral blood and bone marrow during symptomatic allergic rhinitis journal February 2007
Novel vaccines and adjuvants for allergen-specific immunotherapy journal December 2006
Immunotherapy with a Ragweed–Toll-Like Receptor 9 Agonist Vaccine for Allergic Rhinitis journal October 2006
Nonmethylated CG Motifs Packaged into Virus-Like Particles Induce Protective Cytotoxic T Cell Responses in the Absence of Systemic Side Effects journal January 2004
Inflammatory dendritic cells—not basophils—are necessary and sufficient for induction of Th2 immunity to inhaled house dust mite allergen journal September 2010
Development of a Poly (lactic-co-glycolic acid) Particle Vaccine to Protect Against House Dust Mite Induced Allergy journal July 2014
Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization journal September 1997
Peripherally Administered Nanoparticles Target Monocytic Myeloid Cells, Secondary Lymphoid Organs and Tumors in Mice journal April 2013
TLR9-Based Immunotherapy for Allergic Disease journal October 2006
TLR3 but Not TLR7/8 Ligand Induces Allergic Sensitization to Inhaled Allergen journal April 2012
Systemic Administration of Olygodeoxynucleotides with CpG Motifs at Priming Phase Reduces Local Th2 Response and Late Allergic Rhinitis in BALB/c Mice journal September 2007
A limited CpG-containing oligodeoxynucleotide therapy regimen induces sustained suppression of allergic airway inflammation in mice journal January 2014
Allergy, Parasites, and the Hygiene Hypothesis journal April 2002
Myeloid dendritic cells induce Th2 responses to inhaled antigen, leading to eosinophilic airway inflammation journal August 2000
Size-Dependent Uptake of Particles by Pulmonary Antigen-Presenting Cell Populations and Trafficking to Regional Lymph Nodes journal July 2013
CpG oligonucleotide modulation of allergic inflammation journal May 2001
Immunotherapy of Allergic Rhinitis: New Therapeutic Opportunities with Virus-like Particles Filled with Cpg Motifs journal May 2013
CpG Still Rocks! Update on an Accidental Drug journal April 2012
Allergen-independent immunostimulatory sequence oligodeoxynucleotide therapy attenuates experimental allergic rhinitis journal September 2004
Immunomodulatory Effects of CpG Oligodeoxynucleotides on Established Th2 Responses journal November 2002
Opportunities and challenges of the pulmonary route for vaccination journal March 2011
Immunotherapy of allergic diseases by bacterial products journal March 2011
Role of innate immunity in the pathogenesis of allergic rhinitis journal January 2012
Transforming growth factor β and severe asthma: A perfect storm journal October 2014
House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells journal March 2009
Pre-priming: a novel approach to DNA-based vaccination and immunomodulation journal March 2000
Use of CpG oligonucleotides in treatment of asthma and allergic disease journal March 2009
Orchestrating house dust mite-associated allergy in the lung journal September 2011
Nanoparticle conjugation of antigen enhances cytotoxic T-cell responses in pulmonary vaccination journal October 2011
Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis journal January 2014
Eosinophils Are Dispensable for Allergic Remodeling and Immunity in a Model of House Dust Mite–induced Airway Disease journal January 2011
Intranasal Immunotherapy Is More Effective Than Intradermal Immunotherapy for the Induction of Airway Allergen Tolerance in Th2-Sensitized Mice journal April 2003
Immunotherapy of type-1 allergies with virus-like particles and CpG-motifs journal June 2014
Rapid translocation of nanoparticles from the lung airspaces to the body journal November 2010
Assessment of clinical efficacy of CYT003-QbG10 in patients with allergic rhinoconjunctivitis: a phase IIb study: Treatment of allergy with novel immunotherapeutic journal June 2011
Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I/IIa clinical trial journal April 2009
IFN-γ-mediated efficacy of allergen-free immunotherapy using mycobacterial antigens and CpG-ODN journal March 2011
Enhancing Efficacy of Anticancer Vaccines by Targeted Delivery to Tumor-Draining Lymph Nodes journal February 2014
Asthma protection with bacteria - science or fiction? journal May 2011
High doses of CpG oligodeoxynucleotides stimulate a tolerogenic TLR9–TRIF pathway journal May 2013
Update in clinical allergy and immunology journal October 2012
Cutting Edge: Modulation of Airway Inflammation by CpG Oligodeoxynucleotides in a Murine Model of Asthma journal March 1998

Cited By (13)

Interactions Between Nanoparticles and Dendritic Cells: From the Perspective of Cancer Immunotherapy journal September 2018
Spherical Nucleic Acid Nanoparticles: Therapeutic Potential journal June 2018
Biophysical Attributes of CpG Presentation Control TLR9 Signaling to Differentially Polarize Systemic Immune-Responses journal September 2016
Fibronectin EDA and CpG synergize to enhance antigen-specific Th1 and cytotoxic responses journal May 2016
Nanoparticles: augmenting tumor antigen presentation for vaccine and immunotherapy treatments of cancer journal December 2017
CpG oligodeoxynucleotide nanomedicines for the prophylaxis or treatment of cancers, infectious diseases, and allergies journal January 2017
Engineering Immune Tolerance with Biomaterials journal January 2019
Mechanisms of immune regulation in allergic diseases: the role of regulatory T and B cells journal June 2017
The crosstalk between microbiome and asthma: Exploring associations and challenges journal June 2019
Mechanistic insight into the impact of nanomaterials on asthma and allergic airway disease journal November 2017
Clinical use of adjuvants in allergen-immunotherapy journal February 2017
Immune Response of A Novel ATR-AP205-001 Conjugate Anti-hypertensive Vaccine journal October 2017
Immunomodulatory Effects of Adjuvants CPG, MPLA, and BCG on the Derp2-Induced Acute Asthma at Early Life in an Animal Model of BALB/c Mice journal November 2016

Similar Records

Clonorchis sinensis-derived total protein attenuates airway inflammation in murine asthma model by inducing regulatory T cells and modulating dendritic cell functions
Journal Article · Fri Apr 22 00:00:00 EDT 2011 · Biochemical and Biophysical Research Communications · OSTI ID:1222943

Differences in allergic inflammatory responses between urban PM2.5 and fine particle derived from desert-dust in murine lungs
Journal Article · Fri Apr 15 00:00:00 EDT 2016 · Toxicology and Applied Pharmacology · OSTI ID:1222943

Effects of multi-walled carbon nanotubes on a murine allergic airway inflammation model
Journal Article · Mon Jun 15 00:00:00 EDT 2009 · Toxicology and Applied Pharmacology · OSTI ID:1222943